XML 72 R64.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Sales Information [Line Items]      
Number of operating business segment 1nktr_NumberOfOperatingBusinessSegment    
Number of components within business segment 2nktr_NumberOfComponentsWithinBusinessSegment    
Property and equipment, net 70,368us-gaap_PropertyPlantAndEquipmentNet 66,974us-gaap_PropertyPlantAndEquipmentNet  
United States [Member]      
Sales Information [Line Items]      
Property and equipment, net 63,700us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_US
57,300us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_US
 
Percentage of net book value of property and equipment 90.00%nktr_PercentageOfPropertyPlantEquipmentNetInAssets
/ us-gaap_StatementGeographicalAxis
= country_US
88.00%nktr_PercentageOfPropertyPlantEquipmentNetInAssets
/ us-gaap_StatementGeographicalAxis
= country_US
 
India [Member]      
Sales Information [Line Items]      
Property and equipment, net 6,700us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_IN
7,700us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_IN
 
Percentage of net book value of property and equipment 10.00%nktr_PercentageOfPropertyPlantEquipmentNetInAssets
/ us-gaap_StatementGeographicalAxis
= country_IN
12.00%nktr_PercentageOfPropertyPlantEquipmentNetInAssets
/ us-gaap_StatementGeographicalAxis
= country_IN
 
Revenue [Member] | AstraZeneca [Member]      
Sales Information [Line Items]      
Percentage revenue from clients 52.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_AstraZenecaMember
17.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_AstraZenecaMember
 
Revenue [Member] | UCB [Member]      
Sales Information [Line Items]      
Percentage revenue from clients 16.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_UcbPharmaMember
21.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_UcbPharmaMember
30.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_UcbPharmaMember
Revenue [Member] | Roche [Member]      
Sales Information [Line Items]      
Percentage revenue from clients 11.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_RocheMember
28.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_RocheMember
23.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_RocheMember
Revenue [Member] | Bayer [Member]      
Sales Information [Line Items]      
Percentage revenue from clients   10.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_BayerMember
 
Revenue [Member] | Affymax, Inc. [Member]      
Sales Information [Line Items]      
Percentage revenue from clients     11.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= nktr_AffymaxIncMember